Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

592
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
592
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

791
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
791
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Cancer Therapies02:49

Cancer Therapies

8.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K
Cancer02:18

Cancer

51.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Special Focus Issue - Celebrating 40 years of publishing lab techniques: looking back to look foreword.

BioTechniques·2023
Same author

Welcome to the 74th Issue of <i>BioTechniques</i>: 40 years of publishing the latest laboratory protocols.

BioTechniques·2023
Same author

I'm dreaming of a COVID-free Christmas.

BioTechniques·2021
Same author

Reproducibility, scientific rigor and responsibility.

BioTechniques·2021
Same author

Welcome to the 13th Volume of <i>Immunotherapy</i>.

Immunotherapy·2020

Related Experiment Video

Updated: Nov 2, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.3K

Cancer vaccinations: a personalized approach.

Ebony Torrington1

  • 1Future Science Group, Unitec House, 2 Albert Pl, Finchley, London.

Biotechniques
|June 8, 2021
PubMed
Summary

Advancements in messenger RNA (mRNA) technology, immunotherapy, and stem cell technology are paving the way for novel cancer vaccines. These innovations hold significant promise for future cancer treatment strategies.

Area of Science:

  • Oncology
  • Biotechnology
  • Immunology

Background:

  • Cancer vaccines represent a critical frontier in oncology, aiming to harness the immune system for tumor prevention and treatment.
  • Traditional vaccine approaches have faced challenges, necessitating exploration of novel platforms and strategies.

Discussion:

  • Messenger RNA (mRNA) technology offers a versatile platform for encoding tumor-associated antigens, stimulating robust anti-tumor immune responses.
  • Immunotherapy, particularly checkpoint inhibitors, has revolutionized cancer care and can be synergistically combined with vaccine strategies.
  • Stem cell technology provides avenues for developing personalized vaccines and understanding the tumor microenvironment.

Key Insights:

  • The convergence of mRNA, immunotherapy, and stem cell technologies is accelerating the development of effective cancer vaccines.

More Related Videos

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.0K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.7K

Related Experiment Videos

Last Updated: Nov 2, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.3K
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.0K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.7K
  • These integrated approaches aim to overcome immune tolerance and enhance the efficacy of cancer immunotherapy.

    • Outlook:

    • Future research will focus on optimizing vaccine delivery, antigen selection, and combination therapies for improved patient outcomes.
    • Personalized cancer vaccines tailored to individual tumor profiles are anticipated to become a cornerstone of precision oncology.